On Friday, VF Corp (NYSE:VFC)’s shares declined -0.75% to $72.49.
VF Corporation (VFC), a global leader in branded apparel, footwear and accessories, declared that Steven E. Rendle, 55, has been designated President & Chief Operating Officer at the company and has been elected to VF’s Board of Directors. He will report to Eric Wiseman, VF’s Chairman and Chief Executive Officer.
In his role as President & Chief Operating Officer, Rendle will oversee all of VF’s business coalitions worldwide: Outdoor & Action Sports, Jeanswear, Imagewear, Sportswear and Contemporary Brands. He will also be responsible for VF’s global Supply Chain and Direct-to-Consumer platforms.
V.F. Corporation designs, manufactures, markets, and distributes branded lifestyle apparel, footwear, and accessories in the United States and Europe. The company offers outdoor apparel, footwear and equipment, youth culture/action sports-inspired footwear, handbags, luggage, backpacks, totes, accessories, merino wool socks, women’s activewear, and travel accessories under the The North Face, Vans, Timberland, Kipling, Napapijri, Jansport, Reef, Smartwool, Eastpak, lucy, and Eagle Creek brands.
Cardinal Health Inc (NYSE:CAH)’s shares dropped -0.30% to $86.76.
Cardinal Health Inc (CAH) declared the completion of the acquisition of The Harvard Drug Group (THDG). A distributor of generic pharmaceuticals, over-the-counter medications and related products to retail, institutional and alternate care customers, THDG was owned by Court Square Capital Partners. The $1.115 billion acquisition was an all-cash transaction using existing cash and new debt.
Headquartered in Livonia, Mich., The Harvard Drug Group had revenues of about $450 million in 2014. There are 450 employees and two distribution facilities comprised of in the transaction.
In addition to enhancing the company’s generic pharmaceutical distribution business, the acquisition expands Cardinal Health’s existing telesales programs and capabilities; broadens the company’s portfolio of over-the counter pharmaceutical products; and brings specialized packaging offerings to meet the needs of hospital systems and other institutions.
Cardinal Health, Inc., a healthcare services company, provides pharmaceutical and medical products and services in the United States and internationally. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare, specialty pharmaceutical, and consumer products to retailers, including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers; hospitals; and other healthcare providers.
At the end of Friday’s trade, PG&E Corporation (NYSE:PCG)‘s shares dipped -1.80% to $51.33.
PG&E Corporation (PCG) will hold a conference call for members of the financial community on July 29, 2015, at 10:00 a.m. Eastern Time to talk about its first quarter 2015 results. The public can access the conference call via a simultaneous webcast. The link is offered below and will also be accessible from the PG&E Corporation website.
PG&E Corporation, through its partner, Pacific Gas and Electric Company, transmits, delivers, and sells electricity and natural gas to residential, commercial, industrial, and agricultural customers primarily in northern and central California.
Stratasys, Ltd. (NASDAQ:SSYS), ended its Friday’s trading session with -1.76% loss, and closed at $33.59.
Stratasys Ltd. (SSYS), a global leader of 3D printing and additive manufacturing solutions recently declared that it will release financial results for the quarter ended June 30, 2015 on Thursday, July 30, 2015. The Company plans to hold the conference call to talk about its second quarter results on July 30, 2015 at 8:30 a.m. (ET).
Stratasys Ltd. provides additive manufacturing (AM) solutions for the creation of parts used in the processes of designing and manufacturing products; and for the direct manufacture of end parts. Its AM systems utilize its patented fused deposition modeling and inkjet-based PolyJet technologies to enable the production of prototypes, tools used for production and manufactured goods directly from three-dimensional (3D) CAD files or other 3D content.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
